Managing the Adult Patient with Congenital Heart Disease

Meagan King1, Kumar Belani2

  • 1Department of Anesthesiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA; Department of Anesthesiology, University of Minnesota, B515 Mayo, 420 Delaware Street Southeast, Minneapolis, MN 55455, USA.

Anesthesiology Clinics
|August 15, 2020
PubMed

Insights

This review covers common congenital heart disease (CHD) lesions and their perioperative risks for adults undergoing noncardiac surgery. It aims to guide anesthesiologists in managing these complex cardiac conditions.

Area of Science:

  • Anesthesiology
  • Cardiology
  • Adult Congenital Heart Disease

Background:

  • Adults with congenital heart disease (CHD) represent a growing population requiring noncardiac surgical procedures.
  • Managing perioperative risks in this population necessitates a specialized understanding of cardiac anatomy and physiology.
  • General and pediatric anesthesiologists may lack specific expertise in congenital cardiac anesthesia.

Purpose of the Study:

  • To provide a foundational overview of common congenital cardiac lesions.
  • To outline the long-term sequelae associated with these cardiac defects.
  • To highlight expected perioperative concerns for anesthesiologists during noncardiac surgery in adults with CHD.

Main Methods:

  • Review of existing literature on congenital heart disease and anesthesia.
  • Synthesis of information on common cardiac lesions and their management.
  • Focus on perioperative considerations relevant to noncardiac surgery.

Main Results:

  • Detailed descriptions of prevalent congenital cardiac lesions.
  • Explanation of chronic cardiovascular complications stemming from CHD.
  • Identification of key anesthetic challenges and strategies for managing patients with CHD.

Conclusions:

  • A comprehensive understanding of specific CHD lesions is crucial for safe anesthetic practice.
  • Anesthesiologists require basic principles to effectively manage perioperative risks in adults with CHD.
  • This article serves as a guide to enhance the understanding and management of congenital cardiac anesthesia.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
185
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
242
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
130
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
151
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
221
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
166